LN: Lymph Node, RP: Radical Prostatectomy, O: Open, R/L: Robot Assisted/Laparoscopic, ECE: Extracapsular Extension, SV: Seminal Vesicle, G1: Group 1 (<=3 Months), G2 = Group 2 (>3 Months). * x2 Test
Oncological outcomes like the need for adjuvant treatment, PSA recurrence and development of metastasis on follow up were similar between groups in low and intermediate risk patients. (Table 5) In high risk patients adjuvant treatment need rate was higher in group 1 (p=0.023) whereas there was no statistically significant difference between groups with respect to metastasis rate and PSA recurrence rate. (Table 5) Estimated 5-year biochemical recurrence free survival rates were similar in both groups for all three risk categories. (p=0.700, 0.932 and 0.085 respectively) (Figure 1)
Table 5: Oncological Outcomes